Pyrophosphate
|
Basic information |
| Metabolite name | Pyrophosphate |
 | HMDB0000250 |
 |
C00013 |
 |
644102 |
| Synonyms | NA |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | Pyrophosphate |
| HMDB0000250 |
|
C00013 |
|
644102 |
| Synonyms | NA |
| No. of studies | 7 |
|
Relationship between Pyrophosphate and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M082 | Type3 | medium dose of DG group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M082 | Type3 | venlafaxine group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M129 | Type3 | venlafaxine group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Up |
| Study M454 | Type1 | vascular depression model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Ventral hippocampus | C57BL/6 J mouse | Down |
| Study M671 | Type1 | CUMS group vs. control group | Striatum | Sprague-Dawley rat | Up |